Literature DB >> 18205346

Toward quantitative simulations of carbon monoxide escape pathways in myoglobin.

Ron Elber1, Quentin H Gibson.   

Abstract

Straightforward molecular dynamics trajectories have been computed to explore the diffusion of carbon monoxide through myoglobin. The classical equations of motion were integrated for 2 ns and the resulting pathways analyzed. Two types of runs were examined. Type i: Myoglobin and a ligand embedded in a periodic box with 9996 water molecules; the water molecules are rigid but the bonds of the protein are flexible. Type ii: Myoglobin with a solvation shell (153 water molecules) in which all bond lengths are fixed. In trajectories of type i, the diffusing ligand visits a significant part of the protein matrix and was not constrained to the proximity of the heme pocket before escaping. The maximum time of the trajectories was 2 ns. It was shorter if the ligand escaped earlier. Two ligands (from a total of 88) escape to the solvent from nonclassical gates (non-E-helix gates). In trajectories of type ii, the overall fluctuations of the protein are smaller and the ligand explores significantly smaller internal space. The escape rate from type ii trajectories (11 of 400) is comparable to type i and is not dramatically different from experiment (1 of 100). Interestingly, the two simulations with comparable rates sampled different pathways. In trajectories of type ii, we observe escapes from the classical gate (His 64) and from the Xe4 cavity. Further studies (that are underway) are required to define the escape pathways and the overall rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205346     DOI: 10.1021/jp0769779

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  15 in total

1.  An atomistic view on human hemoglobin carbon monoxide migration processes.

Authors:  M Fátima Lucas; Víctor Guallar
Journal:  Biophys J       Date:  2012-02-21       Impact factor: 4.033

2.  Blocking the gate to ligand entry in human hemoglobin.

Authors:  Ivan Birukou; Jayashree Soman; John S Olson
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

3.  Full kinetics of CO entry, internal diffusion, and exit in myoglobin from transition-path theory simulations.

Authors:  Tang-Qing Yu; Mauro Lapelosa; Eric Vanden-Eijnden; Cameron F Abrams
Journal:  J Am Chem Soc       Date:  2015-02-23       Impact factor: 15.419

4.  Systematic multiscale parameterization of heterogeneous elastic network models of proteins.

Authors:  Edward Lyman; Jim Pfaendtner; Gregory A Voth
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

5.  Alkyl isocyanides serve as transition state analogues for ligand entry and exit in myoglobin.

Authors:  George C Blouin; Rachel L Schweers; John S Olson
Journal:  Biochemistry       Date:  2010-06-22       Impact factor: 3.162

6.  Straight-chain alkyl isocyanides open the distal histidine gate in crystal structures of myoglobin .

Authors:  Robert D Smith; George C Blouin; Kenneth A Johnson; George N Phillips; John S Olson
Journal:  Biochemistry       Date:  2010-06-22       Impact factor: 3.162

Review 7.  Ligand diffusion in globins: simulations versus experiment.

Authors:  Ron Elber
Journal:  Curr Opin Struct Biol       Date:  2010-01-29       Impact factor: 6.809

8.  Modulating distal cavities in the α and β subunits of human HbA reveals the primary ligand migration pathway.

Authors:  Ivan Birukou; David H Maillett; Anastasiya Birukova; John S Olson
Journal:  Biochemistry       Date:  2011-08-08       Impact factor: 3.162

9.  Distal histidine stabilizes bound O2 and acts as a gate for ligand entry in both subunits of adult human hemoglobin.

Authors:  Ivan Birukou; Rachel L Schweers; John S Olson
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

10.  A computational study of water and CO migration sites and channels inside myoglobin.

Authors:  Mauro Lapelosa; Cameron F Abrams
Journal:  J Chem Theory Comput       Date:  2013-02-12       Impact factor: 6.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.